The HYLS1 gene helps cells build cilia, which are tiny hairlike structures that guide growth signals during early development. This gene plays an important role in forming the brain and other organs. If the HYLS1 gene does not work properly, cilia may not form as they should, which can lead to major problems with development before birth or in early life. Pathogenic variants in this gene are linked to rare inherited conditions including hydrolethalus syndrome and some forms of Joubert syndrome.
What is a gene?
Genes are stretches of DNA that give cells instructions for making molecules or managing activities in the body. Some genes provide the code to produce proteins, which do much of the cell’s work. Others mainly regulate when certain processes happen, where they take place, and how active they are. Together, genes affect how the body develops and functions, and they can also influence your response to food, stress, and medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
HYLS1Gene function
What if the gene works
The HYLS1 gene helps cells build cilia, tiny hairlike structures that sense signals. This supports normal body patterning and brain, face, and limb development early in pregnancy.
Risk
What if the gene does not work
More disruptive variants in the HYLS1 gene usually cause hydrolethalus syndrome, with brain and body differences before birth. Milder variants may lead to related conditions with variable severity. Pregnancy loss or death around birth is common in severe cases.
Treatment
What does that mean for your treatment
No HYLS1-specific treatment or management approach is currently established; care is supportive and guided by the person’s symptoms and clinical needs rather than by a targeted drug choice linked to the HYLS1 gene.
Conditions associated with HYLS1
Gene function
What if the gene works
Many of your cells use the HYLS1 gene to build cilia, tiny hairlike structures that act like antennae. These structures help cells sense signals and coordinate normal growth and body patterning during development. The HYLS1 gene is especially active at the base of a cilium, where assembly begins.
The HYLS1 gene helps a cell start making a cilium at the right place. Its protein works at the base of the structure, where it supports the early steps of assembly.
This gene helps the cell prepare a centriole (a small organizing structure) to become the cilium’s base. That setup gives the growing cilium a stable anchor and the right orientation.
HYLS1 also supports the ciliary gate, the checkpoint that helps control which proteins enter and leave the cilium. This keeps the cilium’s contents organized so it can work smoothly.
By helping cilia form correctly, the HYLS1 gene supports how cells receive and pass along chemical messages. These signals guide routine cell behavior and many steps of early body development.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effects and simply represent natural genetic variation. In some cases, though, a variant can affect how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
HYLS1 gene variants can change the HYLS1 protein’s shape, stability, or ability to reach the base of cilia, so how HYLS1 gene variants affect protein function often comes down to disrupted cilia building. More disruptive variants may leave little or no working protein, while milder variants may preserve some activity. This range in functional impact can influence how early a HYLS1 related ciliopathy appears and how strongly it affects the body.
How variants are linked to conditions
Pathogenic variants in the HYLS1 gene cause hydrolethalus syndrome 1, a rare inherited condition that affects brain development and the formation of other organs before birth. Among conditions linked to HYLS1 gene variants, this is the main broadly confirmed diagnosis, including a founder variant first described in Finland. When a baby inherits disease-causing HYLS1 variants from both parents, the result can confirm the genetic diagnosis.
A variant is not necessarily a diagnosis
Across the general population, genetic variants are common and are a normal part of human biology. Most do not have a direct effect on health and instead reflect natural human diversity. For many genes, carrying a variant linked to a condition indicates a possible association rather than a definite diagnosis, especially when several genes and environmental factors are involved. Still, in some cases, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For HYLS1, risk is mainly shaped by inheritance rather than lifestyle. A child’s chance of having a HYLS1-related condition is much higher when both parents carry a harmful change in this gene, and this can be more likely in families with a known history or where parents are related by blood. There is not enough evidence to say that diet, exercise, or other everyday factors change this risk.
Inheritance of HYLS1 variants
Variants in the HYLS1 gene are inherited in an autosomal recessive pattern. This means a child has to inherit two disease causing HYLS1 variants, one from each parent, to have a HYLS1 related condition. Parents who each carry one variant are usually unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with neither variant. This HYLS1 gene inheritance pattern affects sons and daughters equally.
What does my HYLS1 result mean for my family?
For families with a disease-causing change in the HYLS1 gene, close relatives may also carry the same gene change, even if they are healthy. Brothers and sisters could be affected or be carriers, and parents are usually carriers. Other relatives, such as aunts, uncles, and cousins, may also carry the change, so the result can matter more widely within the family.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for HYLS1 variants uses a blood, saliva, or cheek swab sample to read the DNA in the HYLS1 gene. It can show whether you carry a variant linked to a HYLS1-related condition, and results are usually reported as pathogenic, benign, or uncertain.
When should I consider getting a genetic test?
Genetic testing for the HYLS1 gene may be worth considering when a pregnancy shows severe birth differences on ultrasound, especially changes affecting the brain, face, or extra fingers or toes, or when hydrolethalus syndrome has affected a previous pregnancy. It can also help families with a known HYLS1 change understand future pregnancy chances.
A genetic result is only one part of your health story
Genetic results can be informative, but how much they reveal varies by the condition and the kind of variant involved. Over time, many other factors also shape how the body works, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, or responds to a drug, so the same treatment may work better for one person than for another. This is common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic differences affect the way people respond to medications. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the HYLS1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in how people respond to medicines, so any concerns about side effects, new symptoms, or treatment choices are best discussed with your doctor.
History
Throughout history, people have described features that hinted at this gene. Hydrolethalus syndrome was recognized for decades as a rare inherited condition, especially in Finland, where repeated family patterns helped researchers suspect a shared genetic cause. In the early 2000s, scientists mapped the condition to chromosome 11 and then identified changes in the HYLS1 gene as the cause in affected families. From these first observations, research expanded steadily, linking a specific founder variant to many Finnish cases. This discovery helped clarify a long-standing medical puzzle and became an important example of how studying founder populations can uncover the genetic basis of rare conditions.